Panacea Acquisition Corp. II

Panacea Acquisition Corp. II (Nasdaq: PANA) is a blank check company sponsored by Panacea Capital Management, a healthcare-focused investment firm led by Kevin Tang. The SPAC completed its initial public offering in 2021 and targets the healthcare and life sciences sector, with a particular emphasis on biopharmaceutical and medical technology businesses. The company filed its annual report on Form 10-K with the SEC on March 30, 2023, covering fiscal year 2022, during which it continued its search for a suitable business combination target. As of the filing date, PANA remained in the search phase and had not announced a definitive merger agreement. For full filings, timeline data, and deal metrics on Panacea Acquisition Corp. II and thousands of other SPACs, sign up for SpacDesk at spacdesk.com.